Largest pharmaceuticals by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 pharmaceuticals ranked by revenue, at PLN 378.8B, ahead of Eli Lilly (PLN 262.1B) and Merck & Co (PLN 261.4B). Figures as of 18 Nov 2026, 15:49 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonPLN 378.8B
- Median
- PLN 12.9B
- Combined market value
- PLN 20.41T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | PLN 378.8B | PLN 2.66T | PLN 1,105.12 | 1.39% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | PLN 262.1B | PLN 4.97T | PLN 5,580.49 | 1.96% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | PLN 261.4B | PLN 1.38T | PLN 560.20 | 2.83% down | 51% up | ||
| 4 | PfizerPFE · Health Care | PLN 251.6B | PLN 644B | PLN 112.98 | 1.32% down | 14% up | ||
| 5 | AbbVieABBV · Health Care | PLN 245.9B | PLN 2.05T | PLN 1,157.92 | 1.66% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | PLN 236.2B | PLN 1.12T | PLN 719.36 | 1.85% down | 2% up | ||
| 7 | NovartisNVS · Health Care | PLN 219.3B | PLN 1.19T | PLN 628.44 | 1.79% down | 25% up | ||
| 8 | SanofiSNY · Health Care | PLN 194.6B | PLN 456.4B | PLN 190.08 | 0.55% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | PLN 193.8B | PLN 492.4B | PLN 240.91 | 2.35% down | 34% up | ||
| 10 | Novo NordiskNVO · Health Care | PLN 184.4B | PLN 701B | PLN 159.06 | 2.81% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | PLN 178.3B | PLN 724B | PLN 418.01 | 0.73% down | 17% down | ||
| 12 | GSKGSK · Health Care | PLN 174.4B | PLN 393.7B | PLN 196.40 | 0.81% down | 6% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | PLN 113.5B | PLN 274.3B | PLN 85.85 | 1.34% down | 54% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 69.4B | PLN 198.1B | PLN 169.74 | 0.96% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | PLN 57.7B | PLN 397.6B | PLN 3,843.03 | 0.22% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | PLN 57.5B | PLN 94.7B | PLN 82.64 | 0.49% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | PLN 48.3B | PLN 543.8B | PLN 2,144.87 | 0.15% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | PLN 38.1B | PLN 136.8B | PLN 336.70 | 0.30% up | 29% down | ||
| 19 | GrifolsGRFS · Health Care | PLN 33.6B | PLN 23.3B | PLN 34.28 | 1.22% down | 1% up | ||
| 20 | BeOne MedicinesONC · Health Care | PLN 21.5B | PLN 185B | PLN 1,619.96 | 2.52% down | 17% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | PLN 19B | PLN 52.9B | PLN 105.88 | 1.86% up | 20% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 17.2B | PLN 62.4B | PLN 972.38 | 0.46% up | 37% up | ||
| 23 | GenmabGMAB · Health Care | PLN 15B | PLN 127.1B | PLN 206.06 | 1.38% down | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | PLN 14.9B | PLN 82.5B | PLN 615.81 | 2.15% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 14.4B | PLN 50.2B | PLN 60.20 | 1.22% up | 5% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | PLN 13B | PLN 46.4B | PLN 239.61 | 1.84% up | 11% up | ||
| 27 | United TherapeuticsUTHR · Health Care | PLN 12.8B | PLN 98.1B | PLN 2,302.73 | 1.96% down | 23% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | PLN 12.1B | PLN 30.1B | PLN 86.35 | 1.67% up | 83% up | ||
| 29 | Royalty PharmaRPRX · Health Care | PLN 9.6B | PLN 158B | PLN 274.77 | 0.51% down | 78% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | PLN 7B | PLN 20.2B | PLN 241.86 | 0.36% down | 20% down | ||
| 31 | AlkermesALKS · Health Care | PLN 5.9B | PLN 31.3B | PLN 186.24 | 1.90% up | 58% up | ||
| 32 | Legend BiotechLEGN · Health Care | PLN 4.1B | PLN 12.6B | PLN 64.94 | 0.25% up | 42% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 3.9B | PLN 38.7B | PLN 1,664.58 | 1.91% down | 24% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | PLN 3.8B | PLN 18.1B | PLN 108.69 | 0.26% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 3.3B | PLN 24.5B | PLN 173.58 | 0.41% up | 10% up | ||
| 36 | Ascendis PharmaASND · Health Care | PLN 3.2B | PLN 71.2B | PLN 1,085.42 | 0.47% down | 28% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | PLN 3.1B | PLN 29.8B | PLN 272.04 | 3.45% down | 8% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 2.7B | PLN 30.1B | PLN 383.31 | 0.22% up | 126% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | PLN 2.6B | PLN 27.9B | PLN 529.74 | 3.10% down | 7% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | PLN 2.5B | PLN 38.5B | PLN 254.63 | 0.97% up | 107% up | ||
| 41 | InsmedINSM · Health Care | PLN 2.4B | PLN 105.1B | PLN 478.95 | 2.26% down | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | PLN 2.1B | PLN 23.9B | PLN 366.42 | 0.90% down | 31% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | PLN 2B | PLN 60.6B | PLN 310.96 | 0.69% up | 17% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | PLN 2B | PLN 19.3B | PLN 200.66 | 2.35% down | 44% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | PLN 1.1B | PLN 23.7B | PLN 1,185.38 | 0.33% up | 43% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 763.1M | PLN 32.6B | PLN 469.96 | 0.22% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | PLN 354M | PLN 28.8B | PLN 206.89 | 0.39% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | PLN 185M | PLN 32.8B | PLN 502.05 | 0.14% up | 46% up | ||
| 49 | Roivant SciencesROIV · Health Care | PLN 33.2M | PLN 112.6B | PLN 155.42 | 0.15% down | 90% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | PLN 8.2M | PLN 19.5B | PLN 345.43 | 1.24% down | 113% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | PLN 0 | PLN 35.9B | PLN 378.04 | 0.21% up | 286% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | PLN 0 | PLN 34.2B | PLN 1,223.91 | 0.23% down | 61% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0213 PLN). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceuticals rank first by revenue?
Johnson & Johnson (PLN 378.8B), Eli Lilly (PLN 262.1B) and Merck & Co (PLN 261.4B) are the top three of the 52 pharmaceuticals ranked by revenue as of 18 Nov 2026, 15:49 UTC.
How many pharmaceuticals are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 52 pharmaceuticals ranked by revenue have a combined market value of PLN 20.41T as of 18 Nov 2026, 15:49 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.